id	sid	eid	entity	type
dpc-1105	2	1	2020;10(4):2020102 1	CARDINAL
dpc-1105	3	1	more than 1	CARDINAL
dpc-1105	5	1	adalimumab	PERSON
dpc-1105	5	2	100	CARDINAL
dpc-1105	5	3	8 weeks	DATE
dpc-1105	6	1	47-year-old	DATE
dpc-1105	6	2	30-year	DATE
dpc-1105	8	1	first	ORDINAL
dpc-1105	8	2	pasi 23.7	PERSON
dpc-1105	8	3	30	CARDINAL
dpc-1105	8	4	bsa	ORG
dpc-1105	8	5	30	CARDINAL
dpc-1105	8	6	80 kg	QUANTITY
dpc-1105	8	7	1	CARDINAL
dpc-1105	8	8	adalimumab aline lissa okita1	PERSON
dpc-1105	8	9	benini1	PERSON
dpc-1105	8	10	denise reis	PERSON
dpc-1105	8	11	1	CARDINAL
dpc-1105	8	12	de mogi das cruzes	ORG
dpc-1105	8	13	são paulo	GPE
dpc-1105	8	14	brazil	GPE
dpc-1105	8	15	secukinumab	GPE
dpc-1105	8	16	adalimumab	PERSON
dpc-1105	8	17	okita al	PERSON
dpc-1105	8	18	longhi d. secukinumab	PERSON
dpc-1105	8	19	adalimumab	PERSON
dpc-1105	10	1	may 28, 2020	DATE
dpc-1105	10	2	october 26, 2020	DATE
dpc-1105	11	1	2020	DATE
dpc-1105	16	1	aline lissa okita	PERSON
dpc-1105	16	2	md	GPE
dpc-1105	16	3	de mogi das cruzes	ORG
dpc-1105	16	4	ave dr cândido x de almeida e souza	PERSON
dpc-1105	16	5	200	CARDINAL
dpc-1105	16	6	são paulo	PERSON
dpc-1105	16	7	brazil	GPE
dpc-1105	18	1	1	CARDINAL
dpc-1105	20	1	2	CARDINAL
dpc-1105	20	2	2020;10(4):2020102 300	CARDINAL
dpc-1105	21	1	3	CARDINAL
dpc-1105	21	2	more than one	CARDINAL
dpc-1105	22	1	3	CARDINAL
dpc-1105	22	2	pasi 75	ORG
dpc-1105	23	1	2	CARDINAL
dpc-1105	24	1	magnano et al	PERSON
dpc-1105	24	2	16	CARDINAL
dpc-1105	24	3	more than 1	CARDINAL
dpc-1105	25	1	secukinumab	PERSON
dpc-1105	25	2	8	CARDINAL
dpc-1105	25	3	100	CARDINAL
dpc-1105	25	4	6	CARDINAL
dpc-1105	25	5	90	CARDINAL
dpc-1105	25	6	2	CARDINAL
dpc-1105	25	7	75	CARDINAL
dpc-1105	26	1	3	CARDINAL
dpc-1105	27	1	2	CARDINAL
dpc-1105	27	2	anti-tnf	NORP
dpc-1105	27	3	4	CARDINAL
dpc-1105	29	1	anti-il12/23	NORP
dpc-1105	29	2	100	CARDINAL
dpc-1105	29	3	8 weeks	DATE
dpc-1105	29	4	secukinumab	PERSON
dpc-1105	32	1	6 months	DATE
dpc-1105	33	1	adalimumab	PERSON
dpc-1105	33	2	pasi 33.6	ORG
dpc-1105	33	3	30	CARDINAL
dpc-1105	33	4	bsa 78	ORG
dpc-1105	33	5	2a	CARDINAL
dpc-1105	33	6	3a	CARDINAL
dpc-1105	34	1	secukinumab 300 mg	PERSON
dpc-1105	34	2	weeks 0	DATE
dpc-1105	34	3	1	DATE
dpc-1105	34	4	2	CARDINAL
dpc-1105	34	5	3	CARDINAL
dpc-1105	34	6	4	CARDINAL
dpc-1105	34	7	75	CARDINAL
dpc-1105	34	8	2b	CARDINAL
dpc-1105	34	9	3b	CARDINAL
dpc-1105	34	10	100	CARDINAL
dpc-1105	34	11	0	CARDINAL
dpc-1105	35	1	week 8	DATE
dpc-1105	36	1	bio-naïve	PERSON
dpc-1105	36	2	pasi 90	ORG
dpc-1105	38	1	one	CARDINAL
dpc-1105	38	2	6	CARDINAL
dpc-1105	38	3	secukinumab	PERSON
dpc-1105	39	1	four	CARDINAL
dpc-1105	39	2	2	CARDINAL
dpc-1105	40	1	12 weeks	DATE
dpc-1105	40	2	4	CARDINAL
dpc-1105	40	3	90	CARDINAL
dpc-1105	40	4	1	CARDINAL
dpc-1105	41	1	235	CARDINAL
dpc-1105	41	2	3	CARDINAL
dpc-1105	41	3	anti-tnf	NORP
dpc-1105	41	4	2	CARDINAL
dpc-1105	42	1	adalimumab	PERSON
dpc-1105	43	1	5 weeks	DATE
dpc-1105	43	2	secukinumab	GPE
dpc-1105	44	1	3	CARDINAL
dpc-1105	45	1	adalimumab	PERSON
dpc-1105	46	1	5 weeks	DATE
dpc-1105	46	2	secukinumab	GPE
dpc-1105	47	1	2020;10(4):2020102 3	CARDINAL
dpc-1105	48	1	2018;79(3	CARDINAL
dpc-1105	50	1	10.1016	CARDINAL
dpc-1105	51	1	3	CARDINAL
dpc-1105	51	2	magnano m	PERSON
dpc-1105	51	3	secukinumab	PERSON
dpc-1105	52	1	j dermatolog	PERSON
dpc-1105	54	1	10.1080/09546634.2018.1427206	CARDINAL
dpc-1105	55	1	29334270	DATE
dpc-1105	56	1	4	CARDINAL
dpc-1105	57	1	pelechas e	GPE
dpc-1105	58	1	secukinumab	GPE
dpc-1105	58	2	il-17a	PRODUCT
dpc-1105	60	1	2017;4(2):509–513	CARDINAL
dpc-1105	60	2	10.1007	CARDINAL
dpc-1105	61	1	pmid	PERSON
dpc-1105	61	2	29022197	DATE
dpc-1105	62	1	1	CARDINAL
dpc-1105	62	2	morgado-carrasco	PERSON
dpc-1105	62	3	alsina gibert m.	PERSON
dpc-1105	62	4	secukinumab	PERSON
dpc-1105	62	5	6	CARDINAL
dpc-1105	64	1	2018;109(6):565-567	CARDINAL
dpc-1105	64	2	10.1016	CARDINAL
dpc-1105	64	3	j. ad.2017.07.019	PERSON
dpc-1105	65	1	pmid	PERSON
dpc-1105	65	2	29169562	CARDINAL
dpc-1105	66	1	2	CARDINAL
dpc-1105	66	2	warren	PERSON
dpc-1105	66	3	barker j	PERSON
dpc-1105	66	4	secukinumab	PERSON
dpc-1105	66	5	the united kingdom	GPE
dpc-1105	66	6	ireland	GPE
dpc-1105	67	1	j am	PERSON